Yuag, Qiana Mae .
HRN: 29-27-82 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/08/2026
AMPICILLIN 250MG (VIAL)
07/08/2026
07/14/2026
IV
160mg
Q12
MAP
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines